1. Assessing user fees under the Prescription Drug User Fee Amendments of 2017 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018 Subject(s): Fees and ChargesInvestigational New Drug Application -- economicsPrescription Drugs -- economicsBiological Products -- economicsOrphan Drug Production -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Drug CostsDrug Industry -- economicsEconomics, Pharmaceutical -- trendsPharmaceutical Research -- economicsPharmaceutical Research -- trendsAntitrust LawsBiological Products -- economicsDrug Approval -- economicsDrug Development -- economicsDrug Development -- trendsEconomic CompetitionForecastingOrphan Drug Production -- economicsTaxesHumansUnited StatesNational Institutes of Health (U.S.)
